Gene Query: REEP5

Dataset Description Geneva Score
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 33.05
Cleavage Factor Im as a key regulator of 3’ UTR length 28.11
The role of FAM46C in myeloma cells [sequencing] 27.69
The role of FAM46C in myeloma cells 27.69
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 26.45
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 24.81
Transcriptomic analysis of LSD1 24.76
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 23.92
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 23.53
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 23.49
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 23.39
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 22.32
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 21.98
Rorc disruption in human FG pancreatic cancer cells 21.98
Transcriptomic analysis of human tonsillar TFH subsets 21.68
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 21.19
Identification of Nrf2 regulated genes by RNA sequencing 20.9
Nrf2 regulated genes in A549 cells 20.9
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 19.39
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 18.78
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 18.68
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 18.09
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 18.09
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 17.79
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 17.51
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 17.2
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 17.12
Genome wide expression change by RNF168 knocking down in MCF-7 cells 16.78
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 16.13
Transcriptome analysis upon C6orf203 silencing 16.06
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 15.81
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 15.7
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 15.63
An optimization system for isolating and sequencing of single human colon cancer cells 15.59
PNET animal model: new insights (II) 15.52
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 15.52
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 15.45
RNA-Seq with and without RNase treatment in PCa cell lines 15.31
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 15.13
Genome wide expression change by RNF168 knocking down in NEC cells 14.46
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 14.31
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 14.1
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 14.04
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 13.89
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 13.64
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 13.59
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 13.58
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 13.5
Unique features and clinical importance of acute alloreactive immune responses 13.47
mRNA-Seq profiling of human developing kidney 13.41
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 13.31
Mapping interactions for the TNIP2 hub protein 13.27
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 13.23
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 13.21
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 13.16
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 13.09
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 12.95
High-Throughput Kinetic Analysis of Fractional Killing 12.64
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 12.53
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 12.46
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 12.45
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 12.45
Transcriptomic analysis of ERR alpha orphan nuclear receptor 12.22
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 12.12
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 11.92
Genome-wide chromatin analysis of Ewing sarcoma 11.92
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.87
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.87
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 11.71
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 11.5
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 11.49
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.41
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.36
Sensing self and nonself circular RNAs 11.32
Effect of Hotair overexpression in human breast cancer cell lines 11.23
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 11.2
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 11.18
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 11.14
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 11.14
Control of prostate tumour growth by the long non-coding RNA GHSROS 11.12
NRDE2 negatively regulates nuclear exosome functions 11.09
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 11.07
Gene expression changes associated with resistance to tagraxofusp (SL-401) 11.06
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 11.05
Ribosomal footprinting of MDA-Parental and MDA-LM2 10.95
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 10.95
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 10.92
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 10.91
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 10.88
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 10.86
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 10.75
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 10.64
Expression profiling of etoposide-induced senescent cells 10.61
Single-nucleotide-resolution mapping of HBV promoters using CAGE 10.6
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 10.56
CROP-Seq in Primary Human T Cells 10.56
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.43
Primary human trophoblast from term placenta 10.31
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.3
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 10.29
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 10.29
The human blood-nerve barrier transcriptome 10.2
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 10.19
Comprehensive comparative analysis of 5’ end RNA sequencing methods 10.16
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 10.13
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 9.98
Transcriptome analysis of kidney organoids 9.97
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 9.96
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 9.94
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.91
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 9.89
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.86
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 9.85
Transcriptome wide analysis of classically and alternatively activated macrophages 9.82
Transcriptomic analysis of the HOTAIR-regulated genes 9.8
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 9.8
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.8
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 9.74
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 9.63
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 9.61
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 9.61
CD73 knockdown effect in pancreatic cancer cell lines 9.61
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.61
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 9.58
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.56
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 9.56
scRNASeq analysis of cycling cardiomyocytes 9.52
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.51
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 9.44
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.41
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 9.4
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 9.4
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 9.37
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.36
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.36
METTL3 promotes translation in human cancer cells 9.34
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 9.11
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 9.1
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.05
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 9.05
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 9.0
NR2F2 study 9.0
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 8.98
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 8.93
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 8.93
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 8.85
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.84
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 8.79
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 8.76
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 8.76
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 8.76
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 8.75
Differentially expressed genes post knock down of lincDUSP26 8.71
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 8.7
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 8.7
RNA-seq of shEZH2 cells 8.67
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 8.66
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 8.66
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 8.64
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 8.64
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 8.61
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 8.61
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 8.6
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.58
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.58
The comparison of high-throughput single-cell RNA-seq methods 8.57
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 8.57
Transciptomic profiling of human fetal lung samples 8.55
Examining serotonergic neuron differentiation from human iPSCs 8.53
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.5
Nucleoporin-mediated regulation of cell identity genes 8.48
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 8.47
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 8.47
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.44
Human HAP1 cells before and after nutrient deprivation 8.44
Stem and effector CD8 T-cells from human cancers 8.43
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 8.38
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 8.28
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 8.27
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 8.26
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 8.26
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 8.25
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.2
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.15
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 8.11
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.1
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 8.09
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 8.01
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 8.01
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 7.98
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.95
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 7.94
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 7.94
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 7.87
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 7.87
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.84
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 7.83
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 7.8
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 7.79
Aging-associated patterns in the expression of human endogenous retroviruses 7.78
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 7.71
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 7.71
RNA-seq melanoma 7.7
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 7.69
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 7.69
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 7.69
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 7.68
T47D RNA-seq and ChrRNA-seq data 7.65
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.65
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 7.63
Identification of renal resident macrophages across species 7.62
hnRNP C is a key regulator of protein synthesis in mitosis 7.51
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.47
Transcriptome-wide identification of CELF2 functional targets in T cells 7.44
Changes in human endometrial gland transcriptome over the window of implantation 7.43
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 7.43
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 7.39
Transcriptomic analyssis following EHMT1/2 inhibition 7.34
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 7.25
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 7.25
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 7.22
Global analysis of enhancer targets: Mosaic-seq 7.21
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 7.19
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.18
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 7.18
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 7.18
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 7.18
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 7.17
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 7.14
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 7.13
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 7.1
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 7.07
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 7.03
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.02
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.02
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 6.98
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 6.95
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 6.93
MARS Seq data from human cortical organoids 6.92
Induced DNA demethylation, genome instability and transcription 6.91
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 6.91
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 6.82
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 6.82
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.82
RNAseq in Alzheimer's Disease patients 6.74
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 6.74
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.67
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 6.66
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 6.66
The interplay between SOX4 and SMAD3 in the context of breast cancer 6.66
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 6.65
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 6.65
Gene expression profile of human placenta from T. Cruzi infected mothers 6.6
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 6.5
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.49
RNA editing in nascent RNA affects pre-mRNA splicing 6.45
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 6.39
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 6.38
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 6.35
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.33
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 6.33
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.26
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 6.24
Mitochondrial dsRNA triggers antiviral signalling in humans 6.16
Knockdown of ADNP in HCT116 colon cancer cells 6.13
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.13
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 6.09
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 6.05
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 6.03
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 6.03
RNA-seq of RKO cells with cTAZ KO or putback 5.98
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.96
RNA-seq analysis of the human fetal kidney. 5.91
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.88
SLIGRL-induced gene expression changes in NHEK cells 5.86
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 5.86
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 5.84
X-Ray induced DNA-Hydroxymethylation changes 5.81
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 5.76
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 5.72
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 5.68
A map of gene expression in neutrophil-like cell lines 5.5
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 5.48
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 5.48
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 5.42
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 5.37
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 5.37
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 5.29
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 5.29
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 5.28
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 5.23
miR941 overexpression experiment 5.2
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 5.2
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 4.99
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 4.99
SLAM-seq for K562 endogenous mRNA decay 4.99
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 4.94
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.87
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 4.84
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 4.79
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 4.79
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 4.75
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 4.73
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.73
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 4.72
Measure transcript integrity using RNA-seq data 4.6
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 4.57
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 4.57
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 4.55
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 4.55
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 4.53
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 4.53
Identification of renal resident macrophages across species [C1] 4.53
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 4.37
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 4.37
Tpl-2 and MEK small molecule inhibitors 4.36
Tpl-2 small molecule project 4.36
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 4.34
Expression profiling of MCF-7 cells with treatment of TCDD 4.34
KSDM1b Role in Ewing Sarcoma 4.33
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 4.32
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 4.27
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 4.27
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 4.19
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.18
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 4.14
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.08
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.04
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.03
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.01
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 3.99
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 3.97
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.93
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.93
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.91
Gene expression profile in breast cancer cells 3.9
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 3.9
Epigenetic reprogramming of melanoma cells by vitamin C treatment 3.88
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.85
nELAVL HITS-CLIP in Alzheimer's Disease patients 3.85
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.82
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 3.77
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.75
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 3.65
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.64
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 3.63
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.55
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 3.51
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 3.47
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.47
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.45
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 3.34
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 3.34
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 3.32
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 3.32
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 3.31
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 3.29
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 3.28
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.26
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 3.23
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 3.23
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.23
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 3.22
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 3.19
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.19
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.19
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.18
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 3.17
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 3.17
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.17
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 3.14
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 3.14
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 3.13
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.09
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.09
The cytokine environment influence on human skin-derived T cells 3.04
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 2.97
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.88
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 2.83
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.82
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.82
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 2.82
Transcriptomic profile of human embryonic renal corpuscles 2.81
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.78
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.77
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 2.76
Transcriptome analysis of peripheral blood monocytes 2.73
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.72
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.72
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 2.71
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 2.69
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 2.69
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.64
A single-cell transcriptome atlas of the human pancreas 2.62
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 2.61
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 2.58
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.56
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.56
RNA Sequencing of Human iPS derived Cardiomyocytes 2.56
Metastasis in triple-negative breast cancer 2.54
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.54
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.5
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.4
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 2.38
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.38
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 2.37
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.34
MAIT cell RNA sequencing 2.28
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 2.28
Be1 and Be2 B cells are transcriptionally distinct 2.27
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 2.22
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.21
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.14
mRNA recovered upon RNF219 IP. [RNA-IP] 2.07
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 2.01
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 1.98
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.97
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.92
Transcriptome-wide response to synthetic chromatin protein PcTF 1.91
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.91
Dilated cardiomyopathy vs Myocarditis 1.83
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 1.82
Transcriptional effect of ETV1 knockdown in melanoma cells 1.82
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 1.81
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.8
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.78
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.69
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.63
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 1.61
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.61
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.61
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 1.59
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.48
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.42
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.39
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 1.38
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.37
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.37
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.31
Enhancer activation during EGF response 1.26
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.21
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.18
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 1.16
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 1.16
p63 controls the enhancer landscape during keratinocyte differentiation 1.14
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.1
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.05
Role of cervicovaginal microbiota in genital inflammation 1.05
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 1.03
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.03
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 0.98
The age and genomic integrity of neurons after cortical stroke in humans 0.95
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.9
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.87
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.87
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.86
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.79
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.71
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.66
Gene expression profiling in metabolically heterogeneous human lung tumors 0.62
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.56
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.54
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.53
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.52
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.51
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.51
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.48
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.48
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 0.48
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.42
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.41
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 0.34
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.34
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.34
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 0.33
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.33
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.31
mRNA-sequencing of breast cancer subtypes and normal tissue 0.3
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.27
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.27
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.27
MHC Transcriptomic landscape at haplotype-specific resolution 0.24
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.23
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.22
Total RNA-Seq data from leukemic patients with complex structural variants 0.21
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.17
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.15
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.14
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.13
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.12
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.11
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.09
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.09
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.05
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.02
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 0.02
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.01
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.0
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation